Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BHMT | Q93088 | 3/20 | 0.49 |
| ▸ | GSR | P00390 | 2/20 | 0.47 |
| ▸ | KIF11 | P52732 | 6/20 | 0.46 |
| ▸ | CPB1 | P15086 | 1/20 | 0.45 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.45 |
| ▸ | GRM8 | O00222 | 1/20 | 0.45 |
| ▸ | GRM6 | O15303 | 1/20 | 0.45 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.45 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.45 |
| ▸ | GRM5 | P41594 | 1/20 | 0.45 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.45 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.45 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.45 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.45 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.45 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.45 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.45 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18894223 | 1.00 | BHMT (0.49) | BHMTGSRKIF11CPB1CPB2 | |
| SCHEMBL19734386 | 0.90 | BHMT (0.45) | BHMTGSRKIF11CPB1CPB2 | |
| SCHEMBL4838885 | 0.83 | BHMT (0.49) | BHMTGSRKIF11GRM8GRM6 | |
| SCHEMBL4837844 | 0.83 | BHMT (0.49) | BHMTGSRKIF11GRM8GRM6 | |
| SCHEMBL14420362 | 0.80 | KIF11 (0.50) | BHMTGSRKIF11GRM8GRM6 | |
| SCHEMBL5697661 | 0.80 | KIF11 (0.50) | BHMTGSRKIF11GRM8GRM6 | |
| SCHEMBL8418914 | 0.80 | KIF11 (0.50) | BHMTGSRKIF11GRM8GRM6 | |
| SCHEMBL19232136 | 0.78 | KIF11 (0.48) | BHMTGSRKIF11GRM8GRM6 | |
| Hydrochloric Acid SCHEMBL319257 | 0.78 | NOS2 (0.50) | BHMTGSRKIF11GRM8GRM6 | |
| Hydrochloric Acid SCHEMBL29213474 | 0.78 | NOS2 (0.50) | BHMTGSRKIF11GRM8GRM6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220226496-A1 | LIGAND-DRUG CONJUGATE INCLUDING LINKER HAVING TRIS STRUCTURE | LEGOCHEM BIOSCIENCES, INC. (KR) | 2022-07-21 | — | — | US | claimed |
| EP-3964236-A1 | LIGAND-DRUG CONJUGATE INCLUDING LINKER HAVING TRIS STRUCTURE | LegoChem Biosciences, Inc. (KR) | 2022-03-09 | — | — | EP | claimed |
| US-11167040-B2 | Conjugates comprising peptide groups and methods related thereto | LEGOCHEM BIOSCIENCES, INC. (KR) | 2021-11-09 | — | — | US | claimed |
| EP-3380125-A1 | CONJUGATES COMPRISING PEPTIDE GROUPS AND METHODS RELATED THERETO | LegoChem Biosciences, Inc. (KR) | 2018-10-03 | — | — | EP | claimed |
| CN-108136038-A | Conjugates comprising peptide groups and methods related thereto | 乐高化学生物科学股份有限公司 | 2018-06-08 | — | — | CN | claimed |
| WO-2017089894-A1 | CONJUGATES COMPRISING PEPTIDE GROUPS AND METHODS RELATED THERETO | LEGOCHEM BIOSCIENCES, INC. (KR) | 2017-06-01 | — | — | WO | claimed |
| US-5658885-A | OLIGOPEPTIDES; ANTICOAGULANTS; ENZYME INHIBITORS; THROMBIN | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-08-19 | — | — | US | claimed |
| US-20260124278-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF NEUROLOGICAL DISORDERS | D&D PHARMATECH INC (KR) | 2026-05-07 | — | — | US | disclosed |
| US-20250296960-A1 | PEPTIDE COMPOSITIONS AND METHODS OF USE THEREOF | D&D PHARMATECH INC. (KR) | 2025-09-25 | — | — | US | disclosed |
| US-20250127723-A1 | PHARMACEUTICAL COMPOSITION COMPRISING LARGE PHYSIOLOGICALLY ACTIVE SUBSTANCE AND EXCIPIENT | D&D PHARMATECH INC. (KR) | 2025-04-24 | — | — | US | disclosed |
| EP-4532530-A1 | PEPTIDE COMPOSITIONS AND METHODS OF USE THREOF | D&D Pharmatech Inc. (KR) | 2025-04-09 | — | — | EP | disclosed |
| EP-4531925-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF NEUROLOGICAL DISORDERS | D&D Pharmatech Inc. (KR) | 2025-04-09 | — | — | EP | disclosed |
| EP-4400094-A1 | PHARMACEUTICAL COMPOSITION COMPRISING LARGE PHYSIOLOGICALLY ACTIVE SUBSTANCE AND EXCIPIENT | D&D Pharmatech Inc. (KR) | 2024-07-17 | — | — | EP | disclosed |
| US-6699855-B2 | PYRROLOPYRAZINONES USEFUL AS SERINE PROTEASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY | 2004-03-02 | — | — | US | disclosed |
| US-20020177725-A1 | Peptide inhibitors of hepatitis C virus NS3 protein | BRISTOL-MYERS SQUIBB COMPANY (FORMERLY D/B/A DUPONT PHARMACEUTICALS COMPANY) | 2002-11-28 | — | — | US | disclosed |
| US-20020123468-A1 | Alpha-ketoamide inhibitors of hepatitis C virus NS3 protease | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2002-09-05 | — | — | US | disclosed |
| US-20020065248-A1 | Inhibitors of hepatitis C virus NS3 protease | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2002-05-30 | — | — | US | disclosed |
| US-5658885-A | OLIGOPEPTIDES; ANTICOAGULANTS; ENZYME INHIBITORS; THROMBIN | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-08-19 | — | — | US | disclosed |
| EP-0787010-A1 | AMIDINO AND GUANIDINO SUBSTITUTED INHIBITORS OF TRYPSIN-LIKE ENZYMES | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-08-06 | — | — | EP | disclosed |
| WO-1996012499-A1 | AMIDINO AND GUANIDINO SUBSTITUTED INHIBITORS OF TRYPSIN-LIKE ENZYMES | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1996-05-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11167040-B2 | Conjugates comprising peptide groups and methods related thereto | DAO, LPO, TYRO3 | BHMT 544/4885GSR 2760/4885KIF11 3435/4885 |
| US-20250127723-A1 | PHARMACEUTICAL COMPOSITION COMPRISING LARGE PHYSIOLOGICALLY ACTIVE SUBSTANCE AND EXCIPIENT | CYP7A1, CYP11B1, CYP11B2 | BHMT 3240/4885GSR 228/4885KIF11 1674/4885 |
| US-20020065248-A1 | Inhibitors of hepatitis C virus NS3 protease | TMPRSS15, CTRC, CPN1 | BHMT 2833/4885GSR 2564/4885KIF11 4542/4885 |
| US-20220226496-A1 | LIGAND-DRUG CONJUGATE INCLUDING LINKER HAVING TRIS STRUCTURE | TNFSF10, TNFRSF9, ANTXR2 | BHMT 4594/4885GSR 4145/4885KIF11 806/4885 |
| US-20020177725-A1 | Peptide inhibitors of hepatitis C virus NS3 protein | VIP, PRSS1, SERPINB1 | BHMT 3408/4885GSR 3815/4885KIF11 4131/4885 |
| US-20250296960-A1 | PEPTIDE COMPOSITIONS AND METHODS OF USE THEREOF | GLP1R, IAPP, GIPR | BHMT 1006/4885GSR 744/4885KIF11 4339/4885 |
| US-20260124278-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF NEUROLOGICAL DISORDERS | GLP1R, IAPP, VIP | BHMT 202/4885GSR 256/4885KIF11 3619/4885 |
| US-20020123468-A1 | Alpha-ketoamide inhibitors of hepatitis C virus NS3 protease | CES1, CYP51A1, SPINT2 | BHMT 2227/4885GSR 3752/4885KIF11 841/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.